PDCD1 and hepatocellular carcinoma: In this study, we employed single cell sequencing technology and integrated data from public databases to comprehensively characterize myeloid and T cells associated with anti-PD-1 therapy in HCC, thereby offering new insights into the mechanisms underlying inadequate treatment responses.